A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting.
about
Survival from XDR-TB is associated with modifiable clinical characteristics in rural South AfricaInfectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.Tuberculosis patients' reasons for, and suggestions to address non-uptake of HIV testing: a cross-sectional study in the Free State Province, South Africa.Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaDisclosure of HIV status: Experiences of Patients Enrolled in an Integrated TB and HAART Pilot Programme in South Africa.Treatment Options for HIV-Associated Tuberculosis.Long-term costs and health impact of continued global fund support for antiretroviral therapyExtensively drug-resistant tuberculosis: a new face to an old pathogen.Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community.Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forwardCo-infection with human immunodeficiency virus and tuberculosis in AsiaIntegrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of careCurrent strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.HIV drug resistance surveillance for prioritizing treatment in resource-limited settings.Tuberculosis and HIV infection: the global setting.Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.Tuberculosis and HIV-Needed: A New Paradigm for the Control and Management of Linked Epidemics.Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.A program to provide antiretroviral therapy to residents of an urban slum in Nairobi, Kenya.Adverse Events in HIV-Infected Persons Receiving Antiretroviral Drug Regimens in a Large Urban Slum in Nairobi, Kenya, 2003-2005.Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.The white and the three-letter plague: integration of TB and HIV care in sub-Saharan AfricaKnowledge and acceptability of HAART among TB patients in Durban, South AfricaCAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial
P2860
Q28481405-3363A49D-9ECF-4F17-A3BA-39E60441A7B6Q30395708-74FD1480-187A-434D-890F-01CDA434CB41Q31012681-99411733-3417-4BA6-882A-C1365A67D041Q33279183-6A0FDB78-0F6A-475D-844A-00D93CA452CCQ33799485-5734D381-1BE6-46D2-B0CC-B7396FBE6F2DQ33813097-45D0FAB2-8ACE-456D-AB9E-47CE93D2309EQ33952153-2B854E11-D3B3-44FA-8F9E-B1E9662738EAQ34453677-72B2C7D6-4373-45BC-B417-2702121712B2Q34453683-6FC099AE-7708-4087-8737-8B5A476FF7D5Q34669435-864C2D22-23CF-4A22-AFAA-57AC88DC3916Q36074442-333E4269-B506-4D91-84F6-A8DFADCD2E45Q36078264-E2DE5E2A-D630-4CDB-AEA7-C77874473B0AQ36530478-8E05774E-738B-4F0C-BE09-EC8EE52D446DQ36576089-F39B691A-84B4-4E4B-BD48-3C27FB4C5E10Q36631571-AFEA6B55-660D-492D-AF53-E769D7DBDB2DQ36877229-0DD675D6-C2C0-4850-AF2C-179DEB4B31B7Q36877237-955EADE6-9284-4CB3-AA89-9D1FC33EBA29Q37379948-DD4E53E4-1EDF-4C29-8DE2-E977CBD49B9BQ37395017-1EE5EB13-44F6-40AF-ABDE-FCB793E0E4D5Q39799201-9D69C78C-7722-47F4-A608-44A5FE91C550Q39805282-2B0F3B2F-2FDC-41DE-820F-F111472D796EQ40867178-0574A877-7B74-481D-89A2-792828F7D020Q42615157-1AE5A1EE-D707-488F-A36F-5A4E34BCCDB9Q55546966-58098373-3670-41D9-BC26-290AABBF964AQ56989629-7F8CC8ED-E787-4412-A20B-B326BFF65DF0Q57980350-A01CBC0C-F19F-43BD-AB7C-66F6EC59825F
P2860
A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A pilot study of once-daily an ...... in a resource-limited setting.
@en
A pilot study of once-daily an ...... in a resource-limited setting.
@nl
type
label
A pilot study of once-daily an ...... in a resource-limited setting.
@en
A pilot study of once-daily an ...... in a resource-limited setting.
@nl
prefLabel
A pilot study of once-daily an ...... in a resource-limited setting.
@en
A pilot study of once-daily an ...... in a resource-limited setting.
@nl
P2093
P50
P1476
A pilot study of once-daily an ...... in a resource-limited setting.
@en
P2093
Christopher Jack
Gerald Friedland
Sharon Cassol
Umesh Lalloo
P304
P356
10.1097/00126334-200408010-00006
P407
P577
2004-08-01T00:00:00Z